Companies/JP/3402

東レ株式会社 · Toray Industries, Inc.

Last · Tokyo¥1222.00-27.00 (-2.16%)close · yahoo · 12h ago
Vol 395.0K ≈ 484.07M
Market cap¥1.78T1.46B sh
P/E · TTM19.3fwd 18.1 · eps 63.17
Beta0.47vs S&P 500
Div yield1.59%annual · TTM
52w range
¥913.70¥1395.00
Volume5.5Msession

Issuer

Legal nameToray Industries, Inc. · 東レ株式会社
HQJapan (JP)
ListingJP 3402
ISINJP3621000003
SectorMaterials
Industry繊維製品
CurrencyJPY
Entity registryedinet:E00873
Org IDE00873
Headline financial metrics
Revenue¥2.59T
Operating income¥97.2B
Net income¥79.5B
Free cash flow¥63.1B
Operating margin3.8%
Net margin3.1%
Return on equity4.4%
Period2026
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Latest call · Q1 2026

Hold rather than buy aggressively.

Toray’s Q1 resilience was supported by front-loaded demand and inventory effects, while Performance Chemicals core operating income is expected to fall by roughly ¥8 billion from Q1 to Q2 as those benefits fade, market prices decline and lactam conditions worsen. The bull case is a broad operational recovery—Ultrasuede, airbag fabrics, MLCC release films, aerospace carbon fiber and water treatment—but earnings quality and cost pass-through remain unsettled.

Themes
  • Performance Chemicals Normalization
  • Inventory Effects
  • Carbon Fiber Aerospace
  • Boeing 787 Supply Chain
  • Cost Pass Through
  • Water Treatment Logistics
+2

Near term

Performance Chemicals is likely to weaken sharply in Q2 as inventory benefits and front-loaded demand normalize; resins face product-price declines, chemicals face worsening lactam conditions, and Soda Aromatic’s contribution ends after the share sale.

Fibers & Textiles should improve sequentially on autumn/winter apparel demand, strong Ultrasuede programs, airbag fabrics and Alcantara programs, but some Japanese industrial-material demand may have been front-loaded.

Carbon Fiber Composite Materials shipments for 787 were about nine aircraft-equivalents per month in Q1; the customer’s planned increase to 10 per month remains dependent on engine availability.

Water-treatment deliveries remain exposed to Strait of Hormuz disruption, alternative-route congestion and raw-material procurement delays despite Toray shifting production between Japan and Saudi Arabia.

Longer term

Aerospace carbon-fiber demand continues to expand, but the timing of Boeing 787 production increases remains constrained by the engine supply chain.

Industrial carbon-fiber applications may be entering recovery after inventory adjustments, with regular-tow pressure-vessel demand showing signs of bottoming and large-tow wind-turbine shipments recovering.

Toray’s ability to preserve margins depends on broader and faster cost pass-through; Films is lagging Resins & Chemicals, while Carbon Fiber Composite Materials remains constrained by long-term formula-based contracts.

New Ultrasuede programs, power-inductor-coil materials in Korea, MLCC release films and aerospace applications are potential mix improvements, but the call did not quantify their contribution or establish durability.

Red flags

Management could not quantify the contribution of front-loaded demand and inventory effects by sub-segment, making Q1 performance quality difficult to assess.

The expected roughly ¥8 billion sequential decline in Performance Chemicals core operating income shows substantial near-term earnings normalization immediately after the strong Q1.

Carbon-fiber cost pass-through is contractually delayed, leaving margin exposure to higher raw-material and fuel costs.

787 production growth depends on engine supply, while water-treatment logistics remain vulnerable to ongoing regional shipping disruption.

No analyst pushback on frontier-model, LLM-vendor or competitive-displacement risks was present in the supplied transcript.

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

Upcoming earnings

1 event
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
$16.08
Est. revenue
693.3B

Earnings transcripts

4 recent

Documents